iLoF
Company details
Company name
iLoF
Company type
Small Enterprise (less than 50 employees and revenues less than 10 MEUR)
Industry sector
Medical
Activity description
iLoF is developing an advanced low-cost stratification device for neurodegenerative diseases’ drug discovery for pre-screening purposes, with a special focus on Alzheimer’s Disease clinical trials.
Company website
https://ilof.tech/
Project information
Technology platform
TP-1: Free-space photonic components and systems
Application domain
Biomedical
Project scope
A feasibility study for design and fabrication of high numerical aperture micro-lenses on cleaved fiber tips.
ACTPHAST Partners
VUB
Project leader
Prof. Dr. Ir. Jurgen Van Erps (VUB)
Project start
May 2021
Project duration
4 months